10.1002/anie.201703398
Angewandte Chemie International Edition
COMMUNICATION
irradiation: they became wrinkled and some cells lost their
cellular integrity. The photodynamic action of Pc1 on biofilms
was significantly lower as compared with AGA405 (Figure S15
and Figure S16, Supporting Information). Even though further
detailed studies are required to determine the target specificity,
the dependence of the uptake of PS, and the photo bactericidal
activity in planktonic cultures and biofilms from bacterial glycan
coat suggests an important role of the nature of polysaccharides
in aPDT.
One of the favorable attributes for a PS to be used in aPDT is
the possibility to implement it in formulations for delivery or for
antibacterial coatings.[22] So far two main strategies were used
for immobilization of PSs to a substrate: covalent coupling[23] and
physical adsorption.[24] The use of reversible bonds such as
and Dagmar Zeuschner (MPI, Münster) are gratefully
acknowledged for SEM sample preparation and Martin Bühner
(nanoAnalytics GmbH, Münster) for the SEM measurements.
Johannes Putze is acknowledged for support with cell culture
experiments and Olena Mantel for excellent technical assistance.
AG thanks Cristian Strassert for support.
Conflict of interest
AG has received travelling grant from GlaxoSmithKline.
Keywords: antibiotic resistance • E. coli • bacterial biofilm •
silicon(IV)phthalocyanine • antibacterial coating
boronate esters can enable the design of new systems with
25]
favorable characteristics.[13,
Boronic acids are known to be
very efficient cross-linkers of poly(vinyl alcohol)(PVA),[26] which
is a water soluble polymer with excellent film-forming and
adhesive properties. The use of PVA-based materials in the
biomedical field is steadily increasing, also due to the wide
availability and low cost of this polymer. We used AGA405 to
promote the cross-linking of PVA via formation of reversible
covalent bonds with the hydroxyl groups present in PVA
repeating units. Indeed, SEM images of obtained the PVA-
AGA405 composite produced by the drop-casting method
showed the formation of a uniform network pattern (Figure 1b).
Light-activated antimicrobial properties of the coverslips coated
with the optimized formulation of PVA-AGA405 were explored
using E. coli strain 536. The extent of the cell inactivation
correlated well with the concentration of the released PS (Figure
S18, Supporting Information). This is consistent with the reports
suggesting that the short life and minimal diffusion of the
generated ROS restrict the oxidative damage to the PS in close
proximity to bacteria. Most likely the highly hydrophilic surface of
the PVA-AGA405 coating resulting from the uptake of water into
the polymeric backbone prevents bacterial adhesion to the
surface.[27] This is a very important and desirable feature of
antibacterial coatings that prevents biofilm formation.[28]
[1]
J. O'Neill, Tackling drug-resistant infections globally: Final report and
recommendations. The review on antimicrobial resistance; London: HM
Government and the Wellcome Trust; 2016.
[2]
[3]
N. Høiby, T. Bjarnsholt, M. Givskov, S. Molin, O. Ciofu, Int. J.
Antimicrob. Agents 2010, 35, 322–332.
a) M. R. Hamblin, T. Hasan, Photochem. Photobiol. Sci. 2004, 3, 436–
450; b) F. Cieplik, L. Tabenski, W. Buchalla, T. Maisch, Front. Microbiol.
2014, 5, 405; c) M. Wainwright, T. Maisch, S. Nonell, K. Plaetzer, A.
Almeida, G. P. Tegos, M. R. Hamblin, Lancet Infect. Dis. 2016, 3099,
1–7.
[4]
W. C. de Melo, P. Avci, M. N. de Oliveria, A. Gupta, D. Vecchio, M.
Sadasivam, R. Chandran, Y.-Y. Huan, R. Yin, L. R. Perussi, G. P.
Tegos, J.R. Perussi, T. Dai, M. R. Hamblin, Expert Rev. Anti. Infect.
Ther. 2013, 11, 669–693.
[5]
[6]
H. Flemming, J. Wingender, Nat. Rev. Microbiol. 2010, 8, 623–33.
a) J. B. Kaplan, Int. J. Artif. Organs 2009, 32, 545–554; b) D. Alves, M.
Olívia Pereira, Biofouling 2014, 30, 483–499.
[7]
a) V. N. Tra, D. H. Dube, Chem. Commun 2014, 50, 4659-4673; b) J. W.
Costerton, R. T. Irvin, K. J. Cheng, Annual Rev. Microbiol. 1981, 35:
299–324.
[8]
[9]
O. Rendueles, J. B. Kaplan, J. M. Ghigo, Environ. Microbiol. 2013, 15,
334–346.
F. Liu, A. Soh Yan Ni, Y. Lim, H. Mohanram, S. Bhattacharjya, B. Xing,
Bioconjugate Chem., 2012, 23 (8), 1639–1647.
[10] P. T. Wong, S. Tang, K. Tang, A. Coulter, J. Mukherjee, K. Gam, J. R.
Baker, Jr., S. Ki Choi, J. Mater. Chem. B, 2015, 1149-1156.
[11] X. Wu, Z. Li, X.-X. Chen, J. S. Fossey, T. D. James, Y.-B. Jiang, Chem.
Soc. Rev. 2013, 42, 8032–8048.
In conclusion, we suggest an effective strategy to modify PSs in
a way that they are able to bind to polysaccharides of the
bacterial cell membrane and biofilm matrix via boronic acid-diol
interaction and destroy it using near-infrared light-mediated PDT.
Moreover the same functionality could be used to implement PS
into PVA based coating. The current results provide new insights
into the formation of dynamic coatings that may have a big
impact in reducing the risk of device-associated infections or can
be used to seal surgical wounds and simultaneously prevent
wound infection. The PVA-AGA405 composite represents a
versatile platform for the development of new materials with a
wide range of application in modern medicine.
[12] W. Yang, X. Gao, B. Wang in Biological and medicinal applications of
boronic acids (Ed. D.G. Hall), Boronic acids: preparation, applications,
in organic synthesis and medicine, Wiley-VCH, Weinheim, 2005, pp.
481–512.
[13] W. L. A. Brooks, B. S. Sumerlin, Chem. Rev. 2016, 116 (3), 1375–1397.
[14] R.E.D. Baron, C.L. Malbasa, D. Santo-Domingo, P. Fu, J.D. Miller, K.K.
Hanneman, A.H. Hsia, N.L. Oleinick, V.C. Colussi, K.D. Cooper. Lasers
Surg Med. 2010, 42, 728-735.
[15] a) A. Galstyan, D. Block, S. Niemann, M. Grüner, S. Abbruzzetti, M.
Oneto, C. G. Daniliuc, S. Hermann, C. Viappiani, M. Schäfers, B. Löffler,
C. A. Strassert, A. Faust Chem. Eur. J. 2016, 22(15), 5243 – 5252; b) A.
Galstyan, U. Kauscher, D. Block, B. J. Ravoo, C. A. Strassert, ACS
Appl. Mater. Interfaces, 2016, 8, 12631 – 12637.
[16] V. Mantareva, I. Angelov, V. Kussovski, R. Dimitrov, L. Lapok, D.
Wöhrle, Eur. J. Med. Chem. 2011, 46, 4430 – 4440.
Acknowledgements
[17] J. W. Costerton, R. T. Irvin, Ann. Rev. Microbiol, 1981, 35, 299–324.
[18] F. F. Sperandio, Y.-Y. Huang, M. R. Hamblin, Recent Pat Antiinfect
Drug Discov 2013, 8, 1–23.
The work of AG was supported by the Deutsche
Forschungsgemeinschaft (DFG), project GA 2362/1-1 and EXC
1003 Cells in Motion – Cluster of Excellence. The work of UD
was supported by the DFG (SFB 1009, TP B05). Karina Mildner
[19] J. M. A. Blair, M. A. Webber, A. J. Baylay, D. O. Ogbolu, L. J. V.
Piddock, Nature Rev. Microbiol. 2015, 13, 42–51.
This article is protected by copyright. All rights reserved.